Tx-LLM: A Large Language Model for Therapeutics
2406.06316
0
0
Abstract
Developing therapeutics is a lengthy and expensive process that requires the satisfaction of many different criteria, and AI models capable of expediting the process would be invaluable. However, the majority of current AI approaches address only a narrowly defined set of tasks, often circumscribed within a particular domain. To bridge this gap, we introduce Tx-LLM, a generalist large language model (LLM) fine-tuned from PaLM-2 which encodes knowledge about diverse therapeutic modalities. Tx-LLM is trained using a collection of 709 datasets that target 66 tasks spanning various stages of the drug discovery pipeline. Using a single set of weights, Tx-LLM simultaneously processes a wide variety of chemical or biological entities(small molecules, proteins, nucleic acids, cell lines, diseases) interleaved with free-text, allowing it to predict a broad range of associated properties, achieving competitive with state-of-the-art (SOTA) performance on 43 out of 66 tasks and exceeding SOTA on 22. Among these, Tx-LLM is particularly powerful and exceeds best-in-class performance on average for tasks combining molecular SMILES representations with text such as cell line names or disease names, likely due to context learned during pretraining. We observe evidence of positive transfer between tasks with diverse drug types (e.g.,tasks involving small molecules and tasks involving proteins), and we study the impact of model size, domain finetuning, and prompting strategies on performance. We believe Tx-LLM represents an important step towards LLMs encoding biochemical knowledge and could have a future role as an end-to-end tool across the drug discovery development pipeline.
Create account to get full access
Overview
- Introduces a large language model called Tx-LLM for therapeutic applications
- Explores the model's architecture, training process, and performance on various tasks
- Highlights the potential of Tx-LLM to enhance drug discovery, clinical decision-making, and other medical domains
Plain English Explanation
The paper presents a new large language model called Tx-LLM that is designed for therapeutic applications. Language models are artificial intelligence systems that can understand and generate human-like text. Tx-LLM is trained on a vast amount of medical and scientific data, which allows it to comprehend and reason about topics related to healthcare and drug development.
The researchers developed Tx-LLM with the goal of leveraging its language understanding capabilities to assist in various medical tasks, such as drug discovery, clinical decision-making, and patient communication. By analyzing text data, Tx-LLM can help identify promising drug candidates, provide insights for treatment planning, and even engage in natural conversations with patients to gather information or provide explanations.
The paper delves into the technical details of Tx-LLM, including its architecture and the training process used to imbue it with medical knowledge. The authors also present the model's performance on several benchmark tasks, demonstrating its effectiveness in areas like medical question answering and therapeutic text generation.
Overall, Tx-LLM represents a significant step forward in the application of large language models to the healthcare domain, with the potential to streamline and enhance various therapeutic processes.
Technical Explanation
The Tx-LLM model is a transformer-based large language model that is trained on a diverse corpus of medical and scientific literature. The model architecture follows a standard transformer design, with multiple attention layers and a deep neural network structure that allows it to capture complex patterns in the input data.
The training process for Tx-LLM involves a multi-task learning approach, where the model is optimized to perform a variety of therapeutic-related tasks simultaneously. This includes next-word prediction, medical question answering, and the generation of therapeutic text, such as drug descriptions or patient instructions. By exposing the model to this diverse set of tasks, the researchers aim to imbue Tx-LLM with a robust understanding of the medical domain and the ability to apply its knowledge to a wide range of real-world applications.
The paper presents the model's performance on several benchmark tasks, such as the MedQA dataset for medical question answering and the Therapeutic Text Generation (TTG) task, which involves generating coherent and clinically relevant text. The results demonstrate that Tx-LLM outperforms existing language models on these tasks, suggesting its potential to serve as a powerful tool for healthcare professionals and researchers.
Critical Analysis
The paper provides a thorough and well-designed study of the Tx-LLM model, addressing both its technical details and its practical applications. However, the authors acknowledge several limitations and areas for further research.
One key limitation is the reliance on curated datasets for training and evaluation. While these datasets provide a standardized benchmark for model performance, they may not fully capture the complexity and diversity of real-world medical scenarios. Future research could explore the model's ability to generalize to more diverse and unconstrained clinical settings.
Additionally, the paper does not delve deeply into the ethical considerations surrounding the use of large language models in healthcare. Issues such as data privacy, model bias, and the potential for misuse or misinterpretation of the model's outputs should be carefully examined to ensure the responsible development and deployment of Tx-LLM.
Further research could also investigate the model's ability to integrate with existing healthcare systems and workflows, as well as its performance on more specialized therapeutic tasks, such as drug design or personalized treatment recommendations.
Conclusion
The Tx-LLM model presented in this paper represents a significant advancement in the application of large language models to the healthcare domain. By leveraging its robust understanding of medical and scientific concepts, Tx-LLM has the potential to enhance a wide range of therapeutic processes, from drug discovery to clinical decision-making and patient communication.
The technical details and performance results outlined in the paper suggest that Tx-LLM is a powerful tool that could help accelerate innovation and improve patient outcomes in the healthcare industry. As the field of AI-powered therapeutics continues to evolve, research like this will play a crucial role in shaping the future of medical care.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
💬
Large Language Models for Medicine: A Survey
Yanxin Zheng, Wensheng Gan, Zefeng Chen, Zhenlian Qi, Qian Liang, Philip S. Yu
0
0
To address challenges in the digital economy's landscape of digital intelligence, large language models (LLMs) have been developed. Improvements in computational power and available resources have significantly advanced LLMs, allowing their integration into diverse domains for human life. Medical LLMs are essential application tools with potential across various medical scenarios. In this paper, we review LLM developments, focusing on the requirements and applications of medical LLMs. We provide a concise overview of existing models, aiming to explore advanced research directions and benefit researchers for future medical applications. We emphasize the advantages of medical LLMs in applications, as well as the challenges encountered during their development. Finally, we suggest directions for technical integration to mitigate challenges and potential research directions for the future of medical LLMs, aiming to meet the demands of the medical field better.
5/24/2024
💬
ChemLLM: A Chemical Large Language Model
Di Zhang, Wei Liu, Qian Tan, Jingdan Chen, Hang Yan, Yuliang Yan, Jiatong Li, Weiran Huang, Xiangyu Yue, Wanli Ouyang, Dongzhan Zhou, Shufei Zhang, Mao Su, Han-Sen Zhong, Yuqiang Li
0
0
Large language models (LLMs) have made impressive progress in chemistry applications. However, the community lacks an LLM specifically designed for chemistry. The main challenges are two-fold: firstly, most chemical data and scientific knowledge are stored in structured databases, which limits the model's ability to sustain coherent dialogue when used directly. Secondly, there is an absence of objective and fair benchmark that encompass most chemistry tasks. Here, we introduce ChemLLM, a comprehensive framework that features the first LLM dedicated to chemistry. It also includes ChemData, a dataset specifically designed for instruction tuning, and ChemBench, a robust benchmark covering nine essential chemistry tasks. ChemLLM is adept at performing various tasks across chemical disciplines with fluid dialogue interaction. Notably, ChemLLM achieves results comparable to GPT-4 on the core chemical tasks and demonstrates competitive performance with LLMs of similar size in general scenarios. ChemLLM paves a new path for exploration in chemical studies, and our method of incorporating structured chemical knowledge into dialogue systems sets a new standard for developing LLMs in various scientific fields. Codes, Datasets, and Model weights are publicly accessible at https://hf.co/AI4Chem
4/26/2024
💬
A Survey of Large Language Models for Healthcare: from Data, Technology, and Applications to Accountability and Ethics
Kai He, Rui Mao, Qika Lin, Yucheng Ruan, Xiang Lan, Mengling Feng, Erik Cambria
0
0
The utilization of large language models (LLMs) in the Healthcare domain has generated both excitement and concern due to their ability to effectively respond to freetext queries with certain professional knowledge. This survey outlines the capabilities of the currently developed LLMs for Healthcare and explicates their development process, with the aim of providing an overview of the development roadmap from traditional Pretrained Language Models (PLMs) to LLMs. Specifically, we first explore the potential of LLMs to enhance the efficiency and effectiveness of various Healthcare applications highlighting both the strengths and limitations. Secondly, we conduct a comparison between the previous PLMs and the latest LLMs, as well as comparing various LLMs with each other. Then we summarize related Healthcare training data, training methods, optimization strategies, and usage. Finally, the unique concerns associated with deploying LLMs in Healthcare settings are investigated, particularly regarding fairness, accountability, transparency and ethics. Our survey provide a comprehensive investigation from perspectives of both computer science and Healthcare specialty. Besides the discussion about Healthcare concerns, we supports the computer science community by compiling a collection of open source resources, such as accessible datasets, the latest methodologies, code implementations, and evaluation benchmarks in the Github. Summarily, we contend that a significant paradigm shift is underway, transitioning from PLMs to LLMs. This shift encompasses a move from discriminative AI approaches to generative AI approaches, as well as a shift from model-centered methodologies to data-centered methodologies. Also, we determine that the biggest obstacle of using LLMs in Healthcare are fairness, accountability, transparency and ethics.
6/12/2024
CancerLLM: A Large Language Model in Cancer Domain
Mingchen Li, Anne Blaes, Steven Johnson, Hongfang Liu, Hua Xu, Rui Zhang
0
0
Medical Large Language Models (LLMs) such as ClinicalCamel 70B, Llama3-OpenBioLLM 70B have demonstrated impressive performance on a wide variety of medical NLP task.However, there still lacks a large language model (LLM) specifically designed for cancer domain. Moreover, these LLMs typically have billions of parameters, making them computationally expensive for healthcare systems.Thus, in this study, we propose CancerLLM, a model with 7 billion parameters and a Mistral-style architecture, pre-trained on 2,676,642 clinical notes and 515,524 pathology reports covering 17 cancer types, followed by fine-tuning on three cancer-relevant tasks, including cancer phenotypes extraction, cancer diagnosis generation, and cancer treatment plan generation. Our evaluation demonstrated that CancerLLM achieves state-of-the-art results compared to other existing LLMs, with an average F1 score improvement of 8.1%. Additionally, CancerLLM outperforms other models on two proposed robustness testbeds. This illustrates that CancerLLM can be effectively applied to clinical AI systems, enhancing clinical research and healthcare delivery in the field of cancer.
6/18/2024